Clinical Trial Update: Inhaled Iloprost and Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating inhaled iloprost effects on exercise hemodynamics and ventricular performance in heart failure with preserved ejection fracti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Iloprost (iloprost)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Heart Failure With Normal Ejection Fraction | Phase 4 | Status: UNKNOWN